AZ Vaccine Safety Review To Give Rapid Answer- But No Guarantee Of EU Consensus
Germany Records Rare Brain Bloodclots
Executive Summary
Member states do not have to follow European Medicines Agency guidance – which means division and confusion could persist after it issues its verdict on the safety of the AstraZeneca vaccine.
You may also be interested in...
Real-World Evidence On COVID 19 Vaccines Coming Into US FDA
Peter Marks says agency is getting first RWE readouts of vaccine safety; AstraZeneca’s vaccine has no expiration date, so stockpile is not currently at risk of being thrown out, the CBER director tells a House hearing.
Sanofi Adds mRNA Specialist Tidal To Acquisition Spree
Sanofi has paid out $160m to add to its in-house expertise in mRNA and novel cell therapy technologies.
AZ’s ‘Long Shot’ COVID-19 Trial Of Diabetes Drug Farxiga Fails
The failure of the SGLT2 inhibitor is not unexpected, but allays any concerns that it could have worsened outcomes for patients with hypertension or heart disease.